Related Experiment Videos
Emotional learning and glutamate: translational perspectives
Charles F Gillespie1, Kerry J Ressler
1Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30329, USA.
CNS Spectrums
|January 10, 2006
Summary
Anxiety disorders involve emotional learning deficits. D-cycloserine, an N-methyl-D-aspartate agonist, shows promise in treating anxiety by enhancing fear extinction, a key component of behavioral therapies.
Area of Science:
- Neuroscience
- Psychiatry
- Behavioral Science
Background:
- Anxiety disorders are prevalent clinical concerns.
- Emotional learning processes are implicated in anxiety.
- Behavioral therapies for anxiety utilize extinction training principles.
Purpose of the Study:
- To review the role of glutamate in fear acquisition and extinction.
- To discuss the potential therapeutic applications of D-cycloserine for anxiety disorders.
Main Methods:
- Review of preclinical research on fear conditioning and extinction in rodent models.
- Analysis of the role of glutamate and N-methyl-D-aspartate receptors in these processes.
- Exploration of D-cycloserine as a modulator of fear extinction.
Main Results:
- Glutamate plays a critical role in both the acquisition and extinction of fear.
- D-cycloserine, a partial N-methyl-D-aspartate agonist, may enhance extinction learning.
- Evidence suggests D-cycloserine could augment the efficacy of exposure-based therapies.
Conclusions:
- Understanding the neurobiology of emotional learning is crucial for anxiety treatment.
- D-cycloserine represents a novel pharmacological approach to enhance fear extinction.
- Targeting glutamate pathways offers promising avenues for treating anxiety disorders.